Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

66.02 -0.31 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,515,535
Open 65.97
Bid (Size) 66.02 (2)
Ask (Size) 66.57 (1)
Prev. Close 66.33
Today's Range 65.82 - 66.89
52wk Range 57.16 - 74.12
Shares Outstanding 1,253,809,440
Dividend Yield 4.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead Sciences Announces Collaboration With Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy to Address Inequities in HIV Care
From Gilead Sciences, Inc.
Via Business Wire
Can Faraday Future (FFIE) Stock Turn Its Cash Crunch Around?
Faraday Future (FFIE) stock is on the move Tuesday as investors react to news of a new funding agreement to keep the business going. 
Via InvestorPlace

Performance

YTD
-9.04%
-9.04%
1 Month
+8.41%
+8.41%
3 Month
+4.50%
+4.50%
6 Month
+7.65%
+7.65%
1 Year
-7.93%
-7.93%

More News

Read More
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,400 Today
Via Benzinga
SoftBank Just Gave Nu Holdings (NU) Stock a Big Boost
Via InvestorPlace
What Is Going on With Gilead Sciences (GILD) Stock Today?
Via InvestorPlace
Gilead Sciences Bets $400M On Inflammatory Diseases Focused UK Based Firm
Via Benzinga
Gilead Sciences' Q2 Beats Street View On Robust Oncology, HIV Product Sales
Via Benzinga
After Surprise Overall Survival Data In Metastatic Breast Cancer, Gilead Takes Complete Rights To Trodelvy
Via Benzinga
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
From Gilead Sciences, Inc.
Via Business Wire
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Why Gilead Sciences Stock Jumped 5% Today
Via Benzinga
Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Gilead Boosts 2022 Guidance On The Back Of Its Covid Treatment
Via Investor's Business Daily
Gilead Shares Climb On Positive Interim Analysis From Late-Stage Breast Cancer Study
Via Benzinga
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study
From Gilead Sciences, Inc.
Via Business Wire
7 Growth Stocks to Buy After a 20% Correction
Via InvestorPlace
3 Best Funds for Aggressive Investors
Via InvestorPlace
Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency
From Gilead Sciences, Inc.
Via Business Wire
August 2022 Stock Considerations
Via Talk Markets
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Via Benzinga
Gilead Sciences to Acquire MiroBio
From Gilead Sciences, Inc.
Via Business Wire
Recession Investing: 5 High Yield Dividend Stocks For A Downturn
Via Benzinga
Gilead Sciences: Q2 Earnings Insights
Via Benzinga
Gilead Sciences Announces Second Quarter 2022 Financial Results
From Gilead Sciences, Inc.
Via Business Wire
Australia's Central Bank Has Raised Its Interest Rate. Business Activity In Europe Is Falling
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account